Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BDH INDUS. vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BDH INDUS.   ACTAVIS
EQUITY SHARE DATA
    BDH INDUS.
Mar-23
ACTAVIS
Dec-18
BDH INDUS./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs21116,159-   
Low Rs9310,840-   
Sales per share (Unadj.) Rs129.33,963.8-  
Earnings per share (Unadj.) Rs14.2-1,276.8-  
Cash flow per share (Unadj.) Rs15.2417.7-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %2.60-  
Book value per share (Unadj.) Rs95.016,349.0-  
Shares outstanding (eoy) m5.76332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.23.4 34.5%   
Avg P/E ratio x10.7-10.6 -100.8%  
P/CF ratio (eoy) x10.032.3 30.8%  
Price / Book Value ratio x1.60.8 193.6%  
Dividend payout %28.10-   
Avg Mkt Cap Rs m8744,489,898 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m700-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m7451,318,372 0.1%  
Other income Rs m825,212 0.0%   
Total revenues Rs m7531,343,584 0.1%   
Gross profit Rs m11034,548 0.3%  
Depreciation Rs m6563,576 0.0%   
Interest Rs m276,078 0.0%   
Profit before tax Rs m111-579,893 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m29-7,349 -0.4%   
Profit after tax Rs m82-424,648 -0.0%  
Gross profit margin %14.72.6 561.4%  
Effective tax rate %25.91.3 2,041.1%   
Net profit margin %11.0-32.2 -34.2%  
BALANCE SHEET DATA
Current assets Rs m605540,727 0.1%   
Current liabilities Rs m246478,345 0.1%   
Net working cap to sales %48.24.7 1,018.2%  
Current ratio x2.51.1 217.4%  
Inventory Days Days320 12.8%  
Debtors Days Days81666 1,230.3%  
Net fixed assets Rs m195149,232 0.1%   
Share capital Rs m580-   
"Free" reserves Rs m4890-   
Net worth Rs m5475,437,670 0.0%   
Long term debt Rs m01,914,801 0.0%   
Total assets Rs m8008,500,316 0.0%  
Interest coverage x71.1-6.6 -1,072.9%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.2 599.9%   
Return on assets %10.4-4.1 -254.8%  
Return on equity %15.0-7.8 -192.1%  
Return on capital %20.5-4.8 -424.0%  
Exports to sales %51.70-   
Imports to sales %29.70-   
Net fx Rs m1630-   
CASH FLOW
From Operations Rs m63471,005 0.0%  
From Investments Rs m5258,756 0.0%  
From Financial Activity Rs m4-808,385 -0.0%  
Net Cashflow Rs m71-78,232 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare BDH INDUS. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BDH INDUS. With: SOTAC PHARMACEUTICALS LTD.  ORTIN LABS   KABRA DRUGS  RPG LIFE SCIENCES  VALIANT LABORATORIES LTD.  



Today's Market

Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5% Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5%(10:30 am)

Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.